Leung; Lai Han

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leung; Lai Han.The latest application filed is for "method of identifying a gene associated with a disease or pathological condition of the disease".

Company Profile

2.8.9

Leung; Lai Han - Taipa MO
Leung; Lai-Han - Macao MO
Leung; Lai Han - MO MO
Leung; Lai-Han - Macau CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of identifying a gene associated with a disease or pathological condition of the disease Grant 10,787,708 - Liu , et al. September 29, 2	2020-09-29
Method Of Identifying A Gene Associated With A Disease Or Pathological Condition Of The Disease App 20190017116 - Liu; Liang ; et al.	2019-01-17
ROS1 inhibitor and its use Grant 9,962,378 - Yao , et al. May 8, 2	2018-05-08
Hydroxynaphthoquinone compounds for treatment of non-small cell lung cancer Grant 9,913,811 - Liu , et al. March 13, 2	2018-03-13
Hydroxynaphthoquinone Compounds For Treatment Of Non-small Cell Lung Cancer App 20170360721 - Liu; Liang ; et al.	2017-12-21
Oncogenic ROS1 and ALK kinase inhibitor Grant 9,782,400 - Yao , et al. October 10, 2	2017-10-10
Pde-delta Inhibitor For The Treatment Of Cancer App 20170135979 - Yao; Xiao Jun ; et al.	2017-05-18
Novel Ros1 Inhibitor And Its Use App 20170079972 - Yao; Xiao Jun ; et al.	2017-03-23
Method for treating gefitinib-resistant non-small-cell lung cancer Grant 9,597,299 - Leung , et al. March 21, 2	2017-03-21
Oncogenic ROS1 kinase inhibitor Grant 9,526,722 - Yao , et al. December 27, 2	2016-12-27
Oncogenic Ros1 Kinase Inhibitor App 20160367546 - YAO; Xiao Jun ; et al.	2016-12-22
Oncogenic Ros1 And Alk Kinase Inhibitor App 20160367547 - Yao; Xiao Jun ; et al.	2016-12-22
Method of treating cancer Grant 9,522,125 - Yao , et al. December 20, 2	2016-12-20
Identification of a new AMPK activator for treatment of lung cancer Grant 9,364,469 - Leung , et al. June 14, 2	2016-06-14
Method For Treating Gefitinib-Resistant Non-Small-Cell Lung Cancer App 20160158163 - LEUNG; Lai-Han ; et al.	2016-06-09
Application of an alkaloid derived from a Chinese herbal for treatment of cancer by inhibiting cholesterol synthesis and fatty acid oxidation App 20150307508 - LEUNG; Lai-Han ; et al.	2015-10-29
Novel Treatment Of Gefitinib-resistant Non-small-cell Lung Cancer App 20140371254 - LEUNG; Lai Han ; et al.	2014-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.